2140 related articles for article (PubMed ID: 33277608)
1. Engineering precision nanoparticles for drug delivery.
Mitchell MJ; Billingsley MM; Haley RM; Wechsler ME; Peppas NA; Langer R
Nat Rev Drug Discov; 2021 Feb; 20(2):101-124. PubMed ID: 33277608
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
[TBL] [Abstract][Full Text] [Related]
3. Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery.
Waheed S; Li Z; Zhang F; Chiarini A; Armato U; Wu J
J Nanobiotechnology; 2022 Aug; 20(1):395. PubMed ID: 36045386
[TBL] [Abstract][Full Text] [Related]
4. An Overview of Drug Delivery Systems.
Jain KK
Methods Mol Biol; 2020; 2059():1-54. PubMed ID: 31435914
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology.
Moghimi SM
Anticancer Agents Med Chem; 2006 Nov; 6(6):553-561. PubMed ID: 17100563
[TBL] [Abstract][Full Text] [Related]
6. Colloidal polymeric nanoparticles and brain drug delivery.
Khalil NM; Mainardes RM
Curr Drug Deliv; 2009 Jul; 6(3):261-73. PubMed ID: 19604140
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles in drug delivery: past, present and future.
Couvreur P
Adv Drug Deliv Rev; 2013 Jan; 65(1):21-3. PubMed ID: 22580334
[TBL] [Abstract][Full Text] [Related]
9. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
[TBL] [Abstract][Full Text] [Related]
10. Delivery of engineered therapeutics and medication.
Wang DA
Pharm Res; 2011 Jun; 28(6):1237-40. PubMed ID: 21491147
[No Abstract] [Full Text] [Related]
11. Pharmaceutical Additive Manufacturing: a Novel Tool for Complex and Personalized Drug Delivery Systems.
Zhang J; Vo AQ; Feng X; Bandari S; Repka MA
AAPS PharmSciTech; 2018 Nov; 19(8):3388-3402. PubMed ID: 29943281
[TBL] [Abstract][Full Text] [Related]
12. Formation, characterization, and fate of inhaled drug nanoparticles.
Zhang J; Wu L; Chan HK; Watanabe W
Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology: a focus on nanoparticles as a drug delivery system.
Kingsley JD; Dou H; Morehead J; Rabinow B; Gendelman HE; Destache CJ
J Neuroimmune Pharmacol; 2006 Sep; 1(3):340-50. PubMed ID: 18040810
[TBL] [Abstract][Full Text] [Related]
14. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders.
Mittal R; Patel AP; Jhaveri VM; Kay SS; Debs LH; Parrish JM; Pan DR; Nguyen D; Mittal J; Jayant RD
Expert Opin Drug Deliv; 2018 Mar; 15(3):301-318. PubMed ID: 29272976
[TBL] [Abstract][Full Text] [Related]
15. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
16. Advances in the treatment of neurodegenerative disorders employing nanoparticles.
Spuch C; Saida O; Navarro C
Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):2-18. PubMed ID: 22272933
[TBL] [Abstract][Full Text] [Related]
17. Challenges in development of nanoparticle-based therapeutics.
Desai N
AAPS J; 2012 Jun; 14(2):282-95. PubMed ID: 22407288
[TBL] [Abstract][Full Text] [Related]
18. Applications of lipid based formulation technologies in the delivery of biotechnology-based therapeutics.
du Plessis LH; Marais EB; Mohammed F; Kotzé AF
Curr Pharm Biotechnol; 2014; 15(7):659-72. PubMed ID: 25091118
[TBL] [Abstract][Full Text] [Related]
19. Safe Nanoparticles: Are We There Yet?
Najahi-Missaoui W; Arnold RD; Cummings BS
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396561
[TBL] [Abstract][Full Text] [Related]
20. Physical and chemical stability of drug nanoparticles.
Wu L; Zhang J; Watanabe W
Adv Drug Deliv Rev; 2011 May; 63(6):456-69. PubMed ID: 21315781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
